MGRX today
$0.18-$0.01 (-7.18%)close Nov 12, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourDescending Triangle
15 minExpanding
5 minConsolidating
Daily trend turns up above $1.25
Key levels
Resistance$0.27
Resistance$0.22
Latest news & SEC filings
LegalMangoceuticals submits draft proxy paperwork and a current report
DealMangoceuticals wraps up direct offering tied to $2.5M MangoRx IP Holdings backing
All MGRX news →About Mangoceuticals
Mangoceuticals is a telehealth-focused company that sells compounded prescription pharmaceutical products and plans to offer men's wellness products through its website. Customers obtain prescriptions via telehealth consultations with contracted physicians, and products are fulfilled by a related-party pharmacy. It operates in the United States, with plans to expand into other jurisdictions such as Mexico and the United Kingdom.
Based on the company's 10-K filed Apr 1, 2026.
Nasdaq · Healthcare
MANGOCEUTICALS, INC. (MGRX)
What Is the Price Target for MGRX?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is MGRX a Buy or Sell Right Now?
Thesis
- •Revenue growing -26.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MGRX.
Start Free Trial →Is MGRX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$1.88
40
Moat Score
NARROW
3/9
Piotroski Score
-5.6
Altman Z-Score
What Is Smart Money Doing with MGRX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cohen Jacob D. | director officer 10% owner | Sale | 2,000,000 | - | Aug 11, 2026 |
| JOHNSTON EUGENE M | officer | Buy | 100,000 | - | Jul 28, 2026 |
| Cohen Jacob D. | director officer 10% owner | Buy | 2,000,000 | - | Jul 28, 2026 |
| Hamilton Alex P. | director | Buy | 100,000 | - | Jul 28, 2026 |
| Cohen Jacob D. | director officer 10% owner | Sale | 500,000 | - | Sep 30, 2025 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MGRX Growth Story
Revenue YoY
-26.0%
3yr Revenue CAGR
270.9%
EPS Growth YoY
54.79%
FCF Growth YoY
N/A%
Revenue Trend
STRONG
Dark Pool Trades for MGRX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MGRX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:56:18 | $0.18 | 2,850 | $$500 | SELL |
| 22:10:29 | $0.18 | 1,012 | $$178 | SELL |
| 21:03:43 | $0.18 | 1,928 | $$347 | SELL |
| 20:55:07 | $0.18 | 1,000 | $$182 | SELL |
| 20:55:07 | $0.18 | 1,000 | $$182 | SELL |
5 dark pool trades shown · $$1K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MANGOCEUTICALS, INC. (MGRX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MGRX — frequently asked questions
What is MGRX stock price today?
MANGOCEUTICALS, INC. (MGRX) is at $0.18, down 7.18% (-$0.01) at the Nov 12, 2026 close.
Why is MGRX stock moving today?
Latest MGRX news — Nov 7, 2026: Mangoceuticals submits draft proxy paperwork and a current report · Oct 9, 2026: Mangoceuticals wraps up direct offering tied to $2.5M MangoRx IP Holdings backing
Did MGRX beat earnings?
MGRX last reported on Aug 13, 2026: EPS -$0.09.
Does MGRX pay a dividend?
Yes. MGRX's dividend yield is 16.75%.
What are MGRX support and resistance levels?
Resistance: $0.22, $0.27, $0.31.
What are insiders doing with MGRX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MGRX?
Nov 7, 2026: Mangoceuticals submits draft proxy paperwork and a current report · Oct 9, 2026: Mangoceuticals wraps up direct offering tied to $2.5M MangoRx IP Holdings backing